Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. [electronic resource]
Producer: 20130426Description: 2349-58 p. digitalISSN:- 1097-0215
- Adult
- Aged
- Alkaline Phosphatase -- blood
- Amylases -- blood
- Analysis of Variance
- Antigens, Neoplasm -- blood
- Apoptosis -- immunology
- Biomarkers, Tumor -- blood
- C-Reactive Protein -- metabolism
- CA-19-9 Antigen -- blood
- Carcinoembryonic Antigen -- blood
- Catheter Ablation
- Cholinesterases -- blood
- Colorectal Neoplasms -- blood
- Deoxyribonucleases -- blood
- Embolization, Therapeutic -- methods
- Female
- HMGB1 Protein -- blood
- Humans
- Kaplan-Meier Estimate
- Keratin-19 -- blood
- L-Lactate Dehydrogenase -- blood
- Lipase -- blood
- Liver Neoplasms -- blood
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multimodal Imaging
- Positron-Emission Tomography
- Prognosis
- Prospective Studies
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic -- blood
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.